Real-world outcomes on platinum-containing chemotherapy for EGFR-mutated advanced nonsquamous NSCLC with prior exposure to EGFR tyrosine kinase inhibitors.
Saved in:
| Title: | Real-world outcomes on platinum-containing chemotherapy for EGFR-mutated advanced nonsquamous NSCLC with prior exposure to EGFR tyrosine kinase inhibitors. |
|---|---|
| Authors: | Halmos B; Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, United States., Rai P; Center for Observational and Real-World Evidence, Merck & Co., Inc., Rahway, NJ, United States., Min J; Center for Observational and Real-World Evidence, Merck & Co., Inc., Rahway, NJ, United States., Hu X; Center for Observational and Real-World Evidence, Merck & Co., Inc., Rahway, NJ, United States., Chirovsky D; Center for Observational and Real-World Evidence, Merck & Co., Inc., Rahway, NJ, United States., Shamoun M; Clinical Research, Merck & Co., Inc., Rahway, NJ, United States., Zhao B; Clinical Research, Merck & Co., Inc., Rahway, NJ, United States. |
| Source: | Frontiers in oncology [Front Oncol] 2024 Apr 18; Vol. 14, pp. 1285280. Date of Electronic Publication: 2024 Apr 18 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38699642 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Real-world outcomes on platinum-containing chemotherapy for EGFR-mutated advanced nonsquamous NSCLC with prior exposure to EGFR tyrosine kinase inhibitors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Halmos+B%22">Halmos B</searchLink>; Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, United States.<br /><searchLink fieldCode="AU" term="%22Rai+P%22">Rai P</searchLink>; Center for Observational and Real-World Evidence, Merck & Co., Inc., Rahway, NJ, United States.<br /><searchLink fieldCode="AU" term="%22Min+J%22">Min J</searchLink>; Center for Observational and Real-World Evidence, Merck & Co., Inc., Rahway, NJ, United States.<br /><searchLink fieldCode="AU" term="%22Hu+X%22">Hu X</searchLink>; Center for Observational and Real-World Evidence, Merck & Co., Inc., Rahway, NJ, United States.<br /><searchLink fieldCode="AU" term="%22Chirovsky+D%22">Chirovsky D</searchLink>; Center for Observational and Real-World Evidence, Merck & Co., Inc., Rahway, NJ, United States.<br /><searchLink fieldCode="AU" term="%22Shamoun+M%22">Shamoun M</searchLink>; Clinical Research, Merck & Co., Inc., Rahway, NJ, United States.<br /><searchLink fieldCode="AU" term="%22Zhao+B%22">Zhao B</searchLink>; Clinical Research, Merck & Co., Inc., Rahway, NJ, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2024 Apr 18; Vol. 14, pp. 1285280. <i>Date of Electronic Publication: </i>2024 Apr 18 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38699642 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2024.1285280 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1285280 Titles: – TitleFull: Real-world outcomes on platinum-containing chemotherapy for EGFR-mutated advanced nonsquamous NSCLC with prior exposure to EGFR tyrosine kinase inhibitors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Halmos B – PersonEntity: Name: NameFull: Rai P – PersonEntity: Name: NameFull: Min J – PersonEntity: Name: NameFull: Hu X – PersonEntity: Name: NameFull: Chirovsky D – PersonEntity: Name: NameFull: Shamoun M – PersonEntity: Name: NameFull: Zhao B IsPartOfRelationships: – BibEntity: Dates: – D: 18 M: 04 Text: 2024 Apr 18 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 14 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |
